Literature DB >> 21600548

Maternal serum folate species in early pregnancy and lower genital tract inflammatory milieu.

Hyagriv N Simhan1, Katherine P Himes, Raman Venkataramanan, Lisa M Bodnar.   

Abstract

OBJECTIVE: We previously reported that elevated antiinflammatory cervical cytokines in early pregnancy were associated with spontaneous preterm birth. Our objective was to explore the relation between serum folate vitamers and the lower genital tract inflammatory milieu. STUDY
DESIGN: Pregnant women (n = 417) at <16 weeks' gestation had serum samples that were analyzed for folate species 5-methyltetrahydrofolate, 5-formyltetrahydrofolate, and cervical fluid that was assayed for cytokine concentrations. Patterns in proinflammatory cytokines (interleukin [IL]-1β, -6, -8, and -10; monocyte chemotactic protein-1) and antiinflammatory cytokines (IL-4, IL-10, IL-13) were identified with factor analysis.
RESULTS: After confounder adjustment, maternal serum 5-methyltetrahydrofolate concentrations had a strong negative association with elevated antiinflammatory scores; serum 5-formyltetrahydrofolate concentrations were associated positively with elevated antiinflammatory scores (both P < .05). Maternal folate was not associated with proinflammatory scores.
CONCLUSION: Maternal serum folate vitamers are associated with cervical cytokine concentrations, which suggests a possible mechanistic link between folate and preterm birth risk.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600548      PMCID: PMC3162114          DOI: 10.1016/j.ajog.2011.03.039

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  Second trimester folate status and preterm birth.

Authors:  Anna Maria Siega-Riz; David A Savitz; Steven H Zeisel; John M Thorp; Amy Herring
Journal:  Am J Obstet Gynecol       Date:  2004-12       Impact factor: 8.661

2.  Easy SAS calculations for risk or prevalence ratios and differences.

Authors:  Donna Spiegelman; Ellen Hertzmark
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

3.  Paternal race and bacterial vaginosis during the first trimester of pregnancy.

Authors:  Hyagriv N Simhan; Lisa M Bodnar; Marijane A Krohn
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

4.  Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done?

Authors:  M L Thompson; J E Myers; D Kriebel
Journal:  Occup Environ Med       Date:  1998-04       Impact factor: 4.402

5.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

6.  Reduction of incidence of prematurity by folic acid supplementation in pregnancy.

Authors:  N Baumslag; T Edelstein; J Metz
Journal:  Br Med J       Date:  1970-01-03

7.  Effect of folic acid plus glycine supplement on uterine prostaglandin and endometrial granulocyte-macrophage colony-stimulating factor expression during early pregnancy in pigs.

Authors:  Frédéric Guay; J Jacques Matte; Christiane L Girard; Marie-France Palin; Alain Giguère; Jean-Paul Laforest
Journal:  Theriogenology       Date:  2004-01-15       Impact factor: 2.740

8.  Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal.

Authors:  Parul Christian; Keith P West; Subarna K Khatry; Steven C Leclerq; Elizabeth K Pradhan; Joanne Katz; Sharada Ram Shrestha; Alfred Sommer
Journal:  Am J Clin Nutr       Date:  2003-12       Impact factor: 7.045

9.  Dietary and serum folate: their influence on the outcome of pregnancy.

Authors:  T O Scholl; M L Hediger; J I Schall; C S Khoo; R L Fischer
Journal:  Am J Clin Nutr       Date:  1996-04       Impact factor: 7.045

10.  Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation.

Authors:  Wafaie Fawzi; Gernard Msamanga; Gretchen Antelman; Chong Xu; Ellen Hertzmark; Donna Spiegelman; David Hunter; Deborah Anderson
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079

View more
  6 in total

1.  Maternal Folate Concentration in Early Pregnancy and Newborn Telomere Length.

Authors:  Sonja Entringer; Elissa S Epel; Jue Lin; Elizabeth H Blackburn; Claudia Buss; Babak Shahbaba; Daniel L Gillen; Raman Venkataramanan; Hyagriv N Simhan; Pathik D Wadhwa
Journal:  Ann Nutr Metab       Date:  2015-06-09       Impact factor: 3.374

2.  The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).

Authors:  C L Raison; A H Miller
Journal:  Mol Psychiatry       Date:  2012-01-31       Impact factor: 15.992

Review 3.  Maternal nutrients and effects of gestational COVID-19 infection on fetal brain development.

Authors:  M Camille Hoffman; Robert Freedman; Amanda J Law; Alena M Clark; Sharon K Hunter
Journal:  Clin Nutr ESPEN       Date:  2021-04-29

4.  Distribution of 5-Methyltetrahydrofolate and Folic Acid Levels in Maternal and Cord Blood Serum: Longitudinal Evaluation of Japanese Pregnant Women.

Authors:  Yoshinori Kubo; Hideoki Fukuoka; Terue Kawabata; Kumiko Shoji; Chisato Mori; Kenichi Sakurai; Masazumi Nishikawa; Takeshi Ohkubo; Kyoichi Oshida; Naotake Yanagisawa; Yuichiro Yamashiro
Journal:  Nutrients       Date:  2020-06-01       Impact factor: 5.717

5.  Folic acid supplementation, preconception body mass index, and preterm delivery: findings from the preconception cohort data in a Chinese rural population.

Authors:  Yuanyuan Wang; Zongfu Cao; Zuoqi Peng; Xiaona Xin; Ya Zhang; Ying Yang; Yuan He; Jihong Xu; Xu Ma
Journal:  BMC Pregnancy Childbirth       Date:  2015-12-15       Impact factor: 3.007

6.  Folic acid protects against lipopolysaccharide-induced preterm delivery and intrauterine growth restriction through its anti-inflammatory effect in mice.

Authors:  Mei Zhao; Yuan-Hua Chen; Xu-Ting Dong; Jun Zhou; Xue Chen; Hua Wang; Shu-Xian Wu; Mi-Zhen Xia; Cheng Zhang; De-Xiang Xu
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.